ICM
OKTA icon

Invenomic Capital Management’s Okta OKTA Stock Holding History

Invenomic Capital Management’s Portfolio OKTA Stock Details OKTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-86,297
Closed -$5.9M – 170
2022
Q4 		$5.9M Sell
86,297
-5,203
-6% -$297K 0.4% 80
2022
Q3 		$5.2M Buy
+91,500
New +$7.87M 0.45% 74

Other funds holding OKTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invenomic Capital Management's OKTA Position: Q1 2023 in Review

Invenomic Capital Management sold out of Okta (OKTA) in Q1 2023, closing a stake of 86,297 shares — an estimated $5.9M sold.

Invenomic Capital Management first reported a position in OKTA in Q3 2022 and held it in 2 quarters. The position peaked at $5.9M in Q4 2022. 635 funds tracked by Wall St. Rank hold OKTA as of Q1 2023.

  • Invenomic Capital Management reported no remaining Okta position as of Q1 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 86,297 Okta shares in Q1 2023, an estimated $5.9M.
  • Invenomic Capital Management first reported a position in Okta in Q3 2022 and held it in 2 quarters.
  • Invenomic Capital Management's Okta position peaked at $5.9M in Q4 2022.
  • 635 funds tracked by Wall St. Rank held Okta as of Q1 2023.

Based on Invenomic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.